In the current study, acute UCN2 dosing agonizes CRHR2 causing insulin resistance in the skeletal muscle, whereas chronic, elevated levels of UCN2 desensitize CRHR2 leading to the opposite: insulin sensitization. This evidence concerns the gene CRHR2 and Insulin resistance.